Search

everythinglearnresearchcommunity

for

Search:↓

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Some children with COVID-19 develop skin symptoms linked to a severe inflammatory condition.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Treatment with dapsone, topical corticosteroids, and antibiotics improved the man's skin conditions.

Turner's syndrome may be linked to autoimmune diseases like psoriasis and alopecia areata, needing comprehensive care.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Hidradenitis suppurativa is a chronic skin disorder linked to genetics, lifestyle, and immune issues, treatable with medications and surgery.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Chronic tonsillitis is linked to NETosis activity, which may help tailor treatments and reduce tonsil removal surgeries.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

SLE is likely one disease with various symptoms, not multiple distinct diseases.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Soft-tissue calcification is rare in systemic lupus erythematosus.

Sarcoidosis can cause various skin issues, making diagnosis difficult.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Acne and hidradenitis suppurativa have different causes and risk factors, but both are driven by inflammation and may benefit from treatments targeting interleukin-1.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Satoyoshi Syndrome is hard to diagnose and treat due to its rarity and complex symptoms.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.